Exhibit 10.3

 

Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 240-24b-2

 

Statement of Work

 

To the Agreement between RADIUS HEALTH, INC. (“RADIUS”) and LONZA Sales AG dated
16 of October 2007

 

Supplemental analytical services

 

Number

 

RDS-001-SC005

 

 

Product Code/Name

 

RDS-001 Abaloparatide

 

 

Description of the proposed change:

 

Manufacturing of an RS solution and supply of 60 extra vials to Vetter. These
vials will be produced together with the 60 vials already ordered (PO# 03329)

Price Agreed

 

[*]€

 

 

Radius

 

Name: Naveen Palwai

Signature: /s/ Naveen Palwai

 

Date : 17 Mar 2016

Radius

 

Name: Wajiha Khan

Signature: /s/ Wajiha Khan

 

Date : March 17, 2016

Lonza Sales AG

 

Name : Paul Tastenhoye

Signature : /s/ Paul Tastenhoye

 

Date: 17/03/2016

Lonza Sales AG

 

Name : Frederique Mutterer

Signature : /s/ Frederique Mutterer

 

Date : 17/03/2016

 

Additional notes: /

 

--------------------------------------------------------------------------------

[*] Certain information in this document has been omitted and filed separately
with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions.

 

1

--------------------------------------------------------------------------------

 

Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 240-24b-2

 

Detailed description of the proposed change

 

Manufacturing of an RS solution and supply of 60 extra vials to Vetter. These
vials will be produced together with the 60 vials already ordered (PO# 03329)

 

Timescale

 

By mid-May.

 

Price and Terms of Payment

 

1.      Price

 

·                  [*]€

 

2.      Payment

 

100% upon completion

 

oooOOOooo

 

--------------------------------------------------------------------------------

[*] Certain information in this document has been omitted and filed separately
with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions.

 

2

--------------------------------------------------------------------------------